Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia

被引:0
|
作者
M. Taj
M. Nadeem
S. Maqsood
T. Shah
T. Farzana
T. S. Shamsi
机构
[1] National Institute of Blood Disease and Bone Marrow Transplantation,Department of Clinical Hematology and Bone Marrow Transplantation
[2] National Institute of Blood Disease and Bone Marrow Transplantation,Head of Clinical Laboratories
[3] National Institute of Blood Disease and Bone Marrow Transplantation,Department of Research and Development
关键词
MASCC score; Hematological disorders; High-risk febrile neutropenia; Low-risk febrile neutropenia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:355 / 360
页数:5
相关论文
共 50 条
  • [21] Effective Antimicrobial Stewardship in Febrile Neutropenia: A Risk Stratification Tool Combining MASCC Score and Procalcitonin Measurements Reduces Antibiotic Duration and Length of Inpatient Stay for Haemato-Oncology Patients
    Pickard, Keir
    Fawcett, Joanna
    Lannon, Michelle
    Creasey, Thomas
    Samuel, Julie
    Langridge, Alexander
    Redding, Nicola
    Acres, Meghan
    Jones, Gail
    [J]. BLOOD, 2022, 140 : 10788 - 10789
  • [22] Procalcitonin (PCT) as an adjunct to the Multinational Association of Supportive Care in Cancer (MASCC) risk-index score in cancer patients with febrile neutropenia
    Uys, A
    Fickl, H
    Meyer, PWA
    Anderson, R
    Rapoport, BL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 759S - 759S
  • [23] Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
    Monuszko, Karen A.
    Albright, Benjamin
    De Oca, Mary Katherine Montes
    Nguyen Thao Thi Nguyen
    Havrilesky, Laura J.
    Davidson, Brittany A.
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [24] SIGNIFICANCE OF FEBRILE NEUTROPENIA RISK SCORE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Vidovic, A.
    Virijevic, M.
    Djunic, I.
    Tomin, D.
    Vukovic, N. Suvajdzic
    Colovic, N.
    Mitrovic, M.
    Arsenijevic, V. Arsic
    Pavlovic, S.
    Mihaljevic, B.
    [J]. HAEMATOLOGICA, 2014, 99 : 574 - 575
  • [25] Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score
    Uys, A
    Rapoport, BL
    Anderson, R
    [J]. SUPPORTIVE CARE IN CANCER, 2004, 12 (08) : 555 - 560
  • [26] Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score
    Almarie Uys
    Bernardo L. Rapoport
    Ronald Anderson
    [J]. Supportive Care in Cancer, 2004, 12 : 555 - 560
  • [27] A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies
    Moreau, M.
    Klastersky, J.
    Schwarzbold, A.
    Muanza, F.
    Georgala, A.
    Aoun, M.
    Loizidou, A.
    Barette, M.
    Costantini, S.
    Delmelle, M.
    Dubreucq, L.
    Vekemans, M.
    Ferrant, A.
    Bron, D.
    Paesmans, M.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (03) : 513 - 519
  • [28] The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score
    A. Carmona-Bayonas
    P. Jiménez-Fonseca
    J. Virizuela Echaburu
    M. Sánchez Cánovas
    F. Ayala de la Peña
    [J]. Clinical and Translational Oncology, 2017, 19 : 1084 - 1090
  • [29] The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    Virizuela Echaburu, J.
    Sanchez Canovas, M.
    Ayala de la Pena, F.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (09): : 1084 - 1090
  • [30] Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study
    Prarthna V. Bhardwaj
    Megan Emmich
    Alexander Knee
    Fatima Ali
    Ritika Walia
    Prithwijit Roychowdhury
    Jackson Clark
    Arthi Sridhar
    Tara Lagu
    Kah Poh Loh
    [J]. Supportive Care in Cancer, 2021, 29 : 5905 - 5914